Ann Rheum Dis. Author manuscript

The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis.

Toonen, E.J.M.
Coenen, M.J.H.
Kievit, W.
Fransen, J.
Eijsbouts, A.M.M.
Scheffer, H.
Radstake, T.R.D.J.
Creemers, M.C.W.
Rooij, D.J. de
Riel, P.L.C.M. van
Franke, B.
Barrera, P.

January 2008

OBJECTIVE: To assess the effect of a functional polymorphism (676T>G, M196R) in the tumour necrosis ...

Genes Are Associated with the Response to TNF Inhibitors in Patients with Rheumatoid Arthritis

Conigliaro Paola
Ciccacci Cinzia
Politi Cristina
Triggianese Paola
Rufini Sara
Kroegler Barbara
Perricone Carlo
Latini Andrea
Novelli Giuseppe
Borgiani Paola
Perricone Roberto

January 2017

) in order to investigate their potential role in the response to therapy with tumor necrosis factor...

Anti-TNF Treatment Response in Rheumatoid Arthritis Patients Is Associated with Genetic Variation in the NLRP3-Inflammasome

Sode Jacob
Vogel Ulla
Bank Steffen
Andersen Paal Skytt
Thomsen Marianne Kragh
Hetland Merete Lund
Locht Henning
Heegaard Niels H. H.
Andersen Vibeke

June 2014

Many patients with rheumatoid arthritis (RA) benefit from tumor necrosis factor-α blocking treatment...

Ann Rheum Dis. Author manuscript

Miceli-richard Corinne
Comets Emmanuelle
Verstuyft C
Tamouza Ryad
Loiseau Pascale
Becquemont Laurent
Charron Dominique
Mariette Xavier

September 2016

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthri...

Published Online First

Inserm U
Et Recherche Clinique
Pr Xavier Mariette
Service De

January 2007

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthri...

4

Verstuyft C
Tamouza R
Loiseau P
Ravaud P
Becquemont L
Charron D
Mariette X

June 2015

1 A single tumor necrosis factor α haplotype influences response to adalimumab in rheumatoid arthrit...

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.

Miceli-Richard, Corinne
Comets, Emmanuelle
Verstuyft, C.
Tamouza, Ryad
Loiseau, Pascale
Ravaud, Philippe
Kupper, H.
Becquemont, Laurent
Charron, Dominique
Mariette, Xavier

April 2008

International audienceOBJECTIVE: To determine whether tumour necrosis factor (TNF) gene polymorphism...

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.

Miceli-Richard, Corinne
Comets, Emmanuelle
Verstuyft, C.
Tamouza, Ryad
Loiseau, Pascale
Ravaud, Philippe
Kupper, H.
Becquemont, Laurent
Charron, Dominique
Mariette, Xavier

April 2008

International audienceOBJECTIVE: To determine whether tumour necrosis factor (TNF) gene polymorphism...

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.

Miceli-Richard, Corinne
Comets, Emmanuelle
Verstuyft, C.
Tamouza, Ryad
Loiseau, Pascale
Ravaud, Philippe
Kupper, H.
Becquemont, Laurent
Charron, Dominique
Mariette, Xavier

April 2008

International audienceOBJECTIVE: To determine whether tumour necrosis factor (TNF) gene polymorphism...

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.

Miceli-Richard, Corinne
Comets, Emmanuelle
Verstuyft, C.
Tamouza, Ryad
Loiseau, Pascale
Ravaud, Philippe
Kupper, H.
Becquemont, Laurent
Charron, Dominique
Mariette, Xavier

April 2008

International audienceOBJECTIVE: To determine whether tumour necrosis factor (TNF) gene polymorphism...

The influence of TNFA genetic polymorphisms in the response to immunomodulatory drugs in patients with rheumatoid arthritis: a systematic review

Clemente, Daniela
Santos, Marlene

September 2013

Etanercept, Infliximab and Adalimumab are the best treatment options for improving the life quality ...

The presence of anti-citrullinated protein antibodies (ACPA) does not affect the clinical response to adalimumab in a group of RA patients with the tumor necrosis factor (TNF) α-308 G/G promoter polymorphism

Soto Sáez, Lilian
Sabugo Siraqyan, María Francisca
Catalán, Diego
Wurmann Kiblisky, Pamela
Cermenatti, Tomás
Gatica Rossi, Héctor
Aravena, Octavio
Salazar, Lorena
Aguillón Gutiérrez, Juan Carlos
Cuchacovich Turteltaub, Miguel

January 2011

Artículo de publicación ISIThe introduction of antitumor necrosis factor (TNF) agents has improved ...

The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis.

Toonen, E.J.M.
Coenen, M.J.H.
Kievit, W.
Fransen, J.
Eijsbouts, A.M.M.
Scheffer, H.
Radstake, T.R.D.J.
Creemers, M.C.W.
Rooij, D.J. de
Riel, P.L.C.M. van
Franke, B.
Barrera, P.

January 2008

Item does not contain fulltextOBJECTIVE: To assess the effect of a functional polymorphism (676T>G, ...

The presence of anti-citrullinated protein antibodies (ACPA) does not affect the clinical response to adalimumab in a group of RA patients with the tumor necrosis factor (TNF) α-308 G/G promoter polymorphism

Soto Sáez, Lilian
Sabugo Siraqyan, María Francisca
Catalán Martina, Diego
Wurmann Kiblisky, Pamela
Cermenatti, Tomás
Gatica Rossi, Héctor
Aravena, Octavio
Salazar, Lorena
Aguillón Gutiérrez, Juan Carlos
Cuchacovich Turteltaub, Miguel

January 2011

Artículo de publicación ISIThe introduction of antitumor necrosis factor (TNF) agents has improved ...

Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy

Tomasz Wysocki
Agnieszka Paradowska-Gorycka

February 2022

Rheumatoid arthritis (RA) is the most commonly occurring chronic inflammatory arthritis, the exact m...

The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis.

Toonen, E.J.M.
Coenen, M.J.H.
Kievit, W.
Fransen, J.
Eijsbouts, A.M.M.
Scheffer, H.
Radstake, T.R.D.J.
Creemers, M.C.W.
Rooij, D.J. de
Riel, P.L.C.M. van
Franke, B.
Barrera, P.

January 2008

OBJECTIVE: To assess the effect of a functional polymorphism (676T>G, M196R) in the tumour necrosis ...

Genes Are Associated with the Response to TNF Inhibitors in Patients with Rheumatoid Arthritis

Conigliaro Paola
Ciccacci Cinzia
Politi Cristina
Triggianese Paola
Rufini Sara
Kroegler Barbara
Perricone Carlo
Latini Andrea
Novelli Giuseppe
Borgiani Paola
Perricone Roberto

January 2017

) in order to investigate their potential role in the response to therapy with tumor necrosis factor...

Anti-TNF Treatment Response in Rheumatoid Arthritis Patients Is Associated with Genetic Variation in the NLRP3-Inflammasome

Sode Jacob
Vogel Ulla
Bank Steffen
Andersen Paal Skytt
Thomsen Marianne Kragh
Hetland Merete Lund
Locht Henning
Heegaard Niels H. H.
Andersen Vibeke

June 2014

Many patients with rheumatoid arthritis (RA) benefit from tumor necrosis factor-α blocking treatment...

Ann Rheum Dis. Author manuscript

Miceli-richard Corinne
Comets Emmanuelle
Verstuyft C
Tamouza Ryad
Loiseau Pascale
Becquemont Laurent
Charron Dominique
Mariette Xavier

September 2016

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthri...

Published Online First

Inserm U
Et Recherche Clinique
Pr Xavier Mariette
Service De

January 2007

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthri...

4

Verstuyft C
Tamouza R
Loiseau P
Ravaud P
Becquemont L
Charron D
Mariette X

June 2015

1 A single tumor necrosis factor α haplotype influences response to adalimumab in rheumatoid arthrit...

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.

Miceli-Richard, Corinne
Comets, Emmanuelle
Verstuyft, C.
Tamouza, Ryad
Loiseau, Pascale
Ravaud, Philippe
Kupper, H.
Becquemont, Laurent
Charron, Dominique
Mariette, Xavier

April 2008

International audienceOBJECTIVE: To determine whether tumour necrosis factor (TNF) gene polymorphism...

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.

Miceli-Richard, Corinne
Comets, Emmanuelle
Verstuyft, C.
Tamouza, Ryad
Loiseau, Pascale
Ravaud, Philippe
Kupper, H.
Becquemont, Laurent
Charron, Dominique
Mariette, Xavier

April 2008

International audienceOBJECTIVE: To determine whether tumour necrosis factor (TNF) gene polymorphism...

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.

Miceli-Richard, Corinne
Comets, Emmanuelle
Verstuyft, C.
Tamouza, Ryad
Loiseau, Pascale
Ravaud, Philippe
Kupper, H.
Becquemont, Laurent
Charron, Dominique
Mariette, Xavier

April 2008

International audienceOBJECTIVE: To determine whether tumour necrosis factor (TNF) gene polymorphism...

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis.

Miceli-Richard, Corinne
Comets, Emmanuelle
Verstuyft, C.
Tamouza, Ryad
Loiseau, Pascale
Ravaud, Philippe
Kupper, H.
Becquemont, Laurent
Charron, Dominique
Mariette, Xavier

April 2008

International audienceOBJECTIVE: To determine whether tumour necrosis factor (TNF) gene polymorphism...

The influence of TNFA genetic polymorphisms in the response to immunomodulatory drugs in patients with rheumatoid arthritis: a systematic review

Clemente, Daniela
Santos, Marlene

September 2013

Etanercept, Infliximab and Adalimumab are the best treatment options for improving the life quality ...

The presence of anti-citrullinated protein antibodies (ACPA) does not affect the clinical response to adalimumab in a group of RA patients with the tumor necrosis factor (TNF) α-308 G/G promoter polymorphism

Soto Sáez, Lilian
Sabugo Siraqyan, María Francisca
Catalán, Diego
Wurmann Kiblisky, Pamela
Cermenatti, Tomás
Gatica Rossi, Héctor
Aravena, Octavio
Salazar, Lorena
Aguillón Gutiérrez, Juan Carlos
Cuchacovich Turteltaub, Miguel

January 2011

Artículo de publicación ISIThe introduction of antitumor necrosis factor (TNF) agents has improved ...

The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis.

Toonen, E.J.M.
Coenen, M.J.H.
Kievit, W.
Fransen, J.
Eijsbouts, A.M.M.
Scheffer, H.
Radstake, T.R.D.J.
Creemers, M.C.W.
Rooij, D.J. de
Riel, P.L.C.M. van
Franke, B.
Barrera, P.

January 2008

Item does not contain fulltextOBJECTIVE: To assess the effect of a functional polymorphism (676T>G, ...

The presence of anti-citrullinated protein antibodies (ACPA) does not affect the clinical response to adalimumab in a group of RA patients with the tumor necrosis factor (TNF) α-308 G/G promoter polymorphism

Soto Sáez, Lilian
Sabugo Siraqyan, María Francisca
Catalán Martina, Diego
Wurmann Kiblisky, Pamela
Cermenatti, Tomás
Gatica Rossi, Héctor
Aravena, Octavio
Salazar, Lorena
Aguillón Gutiérrez, Juan Carlos
Cuchacovich Turteltaub, Miguel

January 2011

Artículo de publicación ISIThe introduction of antitumor necrosis factor (TNF) agents has improved ...

Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy

Tomasz Wysocki
Agnieszka Paradowska-Gorycka

February 2022

Rheumatoid arthritis (RA) is the most commonly occurring chronic inflammatory arthritis, the exact m...

The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis.

Toonen, E.J.M.
Coenen, M.J.H.
Kievit, W.
Fransen, J.
Eijsbouts, A.M.M.
Scheffer, H.
Radstake, T.R.D.J.
Creemers, M.C.W.
Rooij, D.J. de
Riel, P.L.C.M. van
Franke, B.
Barrera, P.

January 2008

OBJECTIVE: To assess the effect of a functional polymorphism (676T>G, M196R) in the tumour necrosis ...

Genes Are Associated with the Response to TNF Inhibitors in Patients with Rheumatoid Arthritis

Conigliaro Paola
Ciccacci Cinzia
Politi Cristina
Triggianese Paola
Rufini Sara
Kroegler Barbara
Perricone Carlo
Latini Andrea
Novelli Giuseppe
Borgiani Paola
Perricone Roberto

January 2017

) in order to investigate their potential role in the response to therapy with tumor necrosis factor...

Anti-TNF Treatment Response in Rheumatoid Arthritis Patients Is Associated with Genetic Variation in the NLRP3-Inflammasome

Sode Jacob
Vogel Ulla
Bank Steffen
Andersen Paal Skytt
Thomsen Marianne Kragh
Hetland Merete Lund
Locht Henning
Heegaard Niels H. H.
Andersen Vibeke

June 2014

Many patients with rheumatoid arthritis (RA) benefit from tumor necrosis factor-α blocking treatment...

Ann Rheum Dis. Author manuscript

Abstract

Extracted data

Ann Rheum Dis. Author manuscript

Abstract

Extracted data

Related items

Related items